Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | daclatasvir | |
| Synonyms |
carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester daclatasvir dihydrochloride BMS-790052-05 BMS-790052 Daklinza |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C549273 |
|
| altLabel |
carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester daclatasvir dihydrochloride BMS-790052-05 BMS-790052 Daklinza
|
|
| cui |
C3252090 C3892852 C2933824 C4046850 C5433251
|
|
| Has mapping qualifier | ||
| HM |
D011759 D002219 D014633/Q000031 D007093
|
|
| Inverse of RB |
LI2427F9CI 50ZO25C11D 0
|
|
| LT |
TRD
|
|
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D007093 http://purl.bioontology.org/ontology/MESH/D014633 |
|
| MDA |
20100511
|
|
| MeSH Frequency |
732
|
|
| MMR |
20201224
|
|
| notation |
C549273
|
|
| prefLabel |
daclatasvir
|
|
| RR |
50ZO25C11D
|
|
| SC |
1
|
|
| Scope Statement |
an HCV NS5A inhibitor
|
|
| SRC |
Nature. 2010 May 6;465(7294):96-100
|
|
| TERMUI |
T001093784 T771029 T001093785 T816670 T000929288 T001093786
|
|
| TH |
NLM (2020) FDA SRS (2017) NLM (2012) NLM (2021) NLM (2010) NLM (2017)
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping